Author name: TB Alliance

TB Alliance announced today that pretomanid (pronounced: pree TOH mah nid) will be the generic, nonproprietary name for its novel

· REMoxTB confirmed the safety of moxifloxacin and its effect in killing TB; results pave way for further study of

Novartis has signed an exclusive worldwide licensing agreement with the Global Alliance for TB Drug Development (TB Alliance) for compounds

TB Alliance, a not-for-profit with the mission of discovering and developing better, faster and affordable treatments, announced the appointment of

TB Alliance, a not-for-profit organization with the mission of developing better, faster and affordable treatments for tuberculosis (TB), announced the

Researchers at the University of Sheffield, Imperial College London, and TB Alliance have found evidence that a large gap exists

Shorter TB treatment regimens will reduce the out-of-pocket expenses incurred by both patients and their family members, who often act

TB Alliance, a not-for-profit organization dedicated to developing better, faster, and affordable treatments for tuberculosis (TB), announced the appointment of